Ready to be prescribed today!
AGEPHA Pharma is proud to announce Aciclovir AGEPHA 30 mg/g eye ointment is now available to be prescribed across the UK.
Aciclovir AGEPHA replaces Zovirax eye ointment, which had been discontinued in 2018. Aciclovir eye ointment is the first line treatment for new and recurrent herpetic keratitis.
Aciclovir Agepha 30 mg/g is the only treatment approved for pregnant women and children.
It is a potent broad-spectrum antiviral agent with a long and stable shelf life. It is listed in the British National Formulary and is covered by the NHS Drug Tariff.
AGEPHA Pharma, founded in Austria over 70 years ago, specialises in ophthalmological pharmaceuticals.